Drugs Containing Excipient (Inactive Ingredient) LYSINE HYDROCHLORIDE

✉ Email this page to a colleague

Branded drugs containing LYSINE HYDROCHLORIDE excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Bracco Diagnostics Inc	KINEVAC	sincalide	0270-0556	LYSINE HYDROCHLORIDE	1969-12-31
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing LYSINE HYDROCHLORIDE excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Bracco Diagnostics Inc	sincalide	0270-0556	LYSINE HYDROCHLORIDE
AstraZeneca Pharmaceuticals LP	anifrolumab-fnia	0310-3040	LYSINE HYDROCHLORIDE
Smith & Nephew Inc	becaplermin	50484-810	LYSINE HYDROCHLORIDE
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.